Ion channels as therapeutic targets in osteoarthritis

Area of Science:

• Biomedical Science
• Molecular Biology
• Pharmacology

Background:

• Osteoarthritis (OA) is a major cause of global disability, marked by cartilage degradation, inflammation, and pain.
• Current treatments for OA lack disease-modifying capabilities, highlighting the need for novel therapeutic targets.
• Ion channels are increasingly recognized as critical regulators in OA pathogenesis, impacting chondrocyte function and pain signaling.

Purpose of the Study:

• To review the multifaceted roles of various ion channel families in osteoarthritis.
• To explore current and emerging therapeutic strategies targeting ion channels for OA treatment.
• To discuss challenges and future directions in developing ion channel-based OA therapies.

Main Methods:

• Comprehensive literature review of preclinical and clinical studies on ion channels in OA.
• Analysis of ion channel families including sodium, potassium, TRP, Piezo, acid-sensing, and chloride channels.
• Examination of therapeutic approaches such as small-molecule inhibitors, biologics, gene therapy, and drug repurposing.

Main Results:

• Ion channels significantly influence chondrocyte survival, mechanotransduction, inflammation, and pain in OA.
• Preclinical and clinical studies show promise for ion channel-targeted therapies in managing OA symptoms and progression.
• Challenges remain in achieving selective targeting, optimizing drug delivery, and stratifying patients for personalized treatment.

Conclusions:

• Ion channel modulation presents a promising avenue for developing novel disease-modifying osteoarthritis treatments.
• Targeted therapies, including precision medicine approaches, are essential to maximize efficacy and minimize side effects.
• Further research into ion channel biology is critical for advancing OA therapeutics and achieving better patient outcomes.